Union Health Minister says India’s healthcare model blends traditional wisdom with modern science, backed by Ayushman Bharat and Janaushadhi expansion
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
The price revision, effective April 3, 2026, brings the innovator molecule within the reach of a significantly larger patient base across the country
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
The inspection is now closed, and no regulatory action has been recommended
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
As Tracky launches integrated health solution
Targets diabetes & obesity crisis as India grapples with soaring metabolic disorders
The once-weekly treatment targets Type 2 Diabetes Mellitus (T2DM) with demonstrated efficacy and safety
Subscribe To Our Newsletter & Stay Updated
